Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
Open data is increasingly common, but when it comes to tackling global disease, more needs to be done.
The Structural Genomics Consortium encourages pharma companies and academics to put all their cards on the table in the interest of speeding up drug research.
Formalised data citation practices would encourage more authors to make their data available for reuse.
In the three months following the Initiative for Open Citations' launch, the percentage of articles with open reference data has moved from 40% to over 45%.
A guide intended to help research funders develop open policies that advance their organizational values.
In a decentralized architecture, anyone has the ability to download and re-host data without changing it's permanent identifier.
Why and how you can open up your data access.
We are delighted to announce the launch of our 2017 survey asking researchers about their use of and attitudes to data, and in particular open data. Take the survey.
FAIR doesn’t actually require the data or software to be openly available.
World-leading research institutes have agreed to join forces with funding agencies and policymakers to create the European Open Science Cloud, the largest shared data repository in history.
Introducing Wide-Open, a system that identifies large number of overdue datasets.
It is surely misguided for funding agencies — for instance, the Swiss National Science Foundation — to prohibit the use of commercial data platforms by grant-holders.
Computational scientists develop a system for spotting data overdue for public release, and end up getting hundreds of open-access datasets corrected.
The rules fail to make data sharing mandatory for papers to be published, which raises the prospect that some authors might decide to ignore the hint.
Supporting the development of new models for open research data in the digital age.
How several free software tools have fundamentally upgraded our approach to collaborative research, making our entire workflow more transparent and streamlined.
Continuous data validation, as a service.
Reflections on Data Sharing at PLOS ONE
Breaking the cycle in which only highly profitable drugs reach the market is not just the responsibility of government.
20 funding organizations and public funding agencies from 11 countries promise that they will require grantees to have plans in place for sharing their results and data ASAP.